§1533 — Title 21 Food and Drugs | U.S. Code

Summary

Give auditors access to books and records for any grant or grant renewal and ask grant recipients for information to check they meet the rules in section 1532(a). Issue a request for proposals that explains how to apply, how renewals work, and how renewals can be suspended or withheld. All applications must be in writing and reviewed. Try to keep reporting short and speed up renewal applications as much as the law allows. Collect data from national substance‑use organizations, eligible coalitions, federal/state/local agencies, tribal governments, and other related groups. Evaluate specific initiatives and the whole program, and share results with coalitions, other organizations, and the public. Work with the Advisory Commission and the National Community Antidrug Coalition Institute. Funds for program evaluations cannot come from section 1524(a), except amounts under section 1524(b) for administrative costs.

Title 21, §1533

Food and Drugs — Source: USLM XML via OLRC

(a)(1)For the purpose of audit and examination, the Administrator—

(A)shall have access to any books, documents, papers, and records that are pertinent to any grant or grant renewal request under this subchapter; and

(B)may periodically request information from a grant recipient to ensure that the grant recipient meets the applicable criteria under section 1532(a) of this title.

(2)The Administrator shall issue a request for proposal regarding, with respect to the grants awarded under section 1532 of this title, the application process, grant renewal, and suspension or withholding of renewal grants. Each application under this paragraph shall be in writing and shall be subject to review by the Administrator.

(3)The Administrator shall, to the maximum extent practicable and in a manner consistent with applicable law, minimize reporting requirements by a grant recipient and expedite any application for a renewal grant made under this part.

(b)(1)The Administrator may collect data from—

(A)national substance use and misuse organizations that work with eligible coalitions, community anti-drug coalitions, departments or agencies of the Federal Government, or State or local governments and the governing bodies of Indian tribes; and

(B)any other entity or organization that carries out activities that relate to the purposes of the Program.

(2)The Administrator may—

(A)evaluate the utility of specific initiatives relating to the purposes of the Program;

(B)conduct an evaluation of the Program; and

(C)disseminate information described in this subsection to—

(i)eligible coalitions and other substance use and misuse organizations; and

(ii)the general public.

(3)The Administrator shall carry out activities under this subsection in consultation with the Advisory Commission and the National Community Antidrug Coalition Institute.

(4)Amounts for activities under paragraph (2)(B) may not be derived from amounts under section 1524(a) of this title except for amounts that are available under section 1524(b) of this title for administrative costs.

Notes & Related Subsidiaries

Editorial Notes

Amendments

2019—Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), made technical amendment to directory language of Pub. L. 115–271, § 8203(b)(4)(A). See 2018 Amendment note below. 2018—Subsec. (b)(1)(A), (2)(C)(i). Pub. L. 115–271, § 8203(b)(4)(A), as amended by Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), substituted “substance use and misuse” for “substance abuse”. 2001—Subsec. (b)(3). Pub. L. 107–82, § 1(e), added par. (3). Subsec. (b)(4). Pub. L. 107–82, § 1(f), added par. (4).

Statutory Notes and Related Subsidiaries

Effective Date

of 2019 AmendmentAmendment by Pub. L. 116–74 effective as if included in the enactment of subtitle K of title VIII of Pub. L. 115–271, see section 2(c)(2) of Pub. L. 116–74, set out as a note under section 1522 of this title.

§1533 Information Collection and Dissemination with Respect to Grant Recipients